Literature DB >> 7387962

Development of chronic conjunctivitis with scarring and pannus, resembling trachoma, in guinea-pigs.

M A Monnickendam, S Darougar, J D Treharne, A M Tilbury.   

Abstract

Guinea-pigs were repeatedly infected with guinea-pig inclusion conjunctivitis agent. Reinfection caused severe conjunctival inflammation, and repeated reinfection led to chronic inflammation lasting for many months. This was followed by the development of pannus, follicles on the palpebral conjunctivae, scarring of the lower palpebral conjunctiva, and deformities of the lower lid. Reinfection was accompanied by small numbers of inclusion-bearing cells, small numbers of polymorphonuclear cells, and high numbers of mononuclear cells. There was no increase in the level of serum antibodies. The chronic conjunctivitis was associated with high numbers of mononuclear cells and no inclusions or polymorphonuclear cells. The response to reinfection appears to be a delayed-type hypersensitivity reaction, and we suggest that the chronic inflammation, pannus, scarring, and lid deformities associated with hyperendemic trachoma may be due to repeated reinfection combined with delayed-type hypersensitivity.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7387962      PMCID: PMC1043671          DOI: 10.1136/bjo.64.4.284

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  11 in total

1.  Immunity to chlamydial infections of the eye. IV. Immunity in owl monkeys to reinfection with trachoma.

Authors:  C E Fraser; D E McComb; E S Murray; A B MacDonald
Journal:  Arch Ophthalmol       Date:  1975-07

2.  The prevention of blindness from trachoma.

Authors:  B R Jones
Journal:  Trans Ophthalmol Soc U K       Date:  1975-04

3.  Immunity to chlamydial infections of the eye. 3. Presence and duration of delayed hypersensitivity to guinea pig inclusion conjuctivitis.

Authors:  R R Watson; A B MacDonald; E S Murray; F Z Modabber
Journal:  J Immunol       Date:  1973-08       Impact factor: 5.422

4.  Pannus with experimental trachoma and inclusion conjunctivitis agent infection of Taiwan monkeys.

Authors:  S P Wang; J T Grayston
Journal:  Am J Ophthalmol       Date:  1967-05       Impact factor: 5.258

5.  Experimental inclusion conjunctivitis in man. II. Partial resistance to reinfection.

Authors:  C Dawson; E Jawetz; L Hanna; L Rose; T R Wood; P Thygeson
Journal:  Am J Epidemiol       Date:  1966-11       Impact factor: 4.897

6.  Inclusion conjunctivitis in the guinea pig.

Authors:  J J Kazdan; J Schachter; M Okumoto
Journal:  Am J Ophthalmol       Date:  1967-07       Impact factor: 5.258

7.  Resistance to reinfection with a chlamydial agent (guinea pig inclusion conjunctivitis agent).

Authors:  A Ahmad; C R Dawson; C Yoneda; B Togni; J Schachter
Journal:  Invest Ophthalmol Vis Sci       Date:  1977-06       Impact factor: 4.799

8.  Immunologic studies in guinea pigs with guinea pig inclusion conjunctivitis (GP-IC) Bedsonia.

Authors:  E S Murray; F T Radcliffe
Journal:  Am J Ophthalmol       Date:  1967-05       Impact factor: 5.258

9.  Immunity to chlamydial infections of the eye. II. Studies of passively transferred serum antibody in resistance to infection with guinea pig inclusion conjunctivitis.

Authors:  R R Watson; J D Mull; A B MacDonald; S E Thompson; S E Bear
Journal:  Infect Immun       Date:  1973-04       Impact factor: 3.441

10.  Guinea-pig inclusion conjunctivitis as a model for the study of trachoma: clinical, microbiological, serological, and cytological studies of primary infection.

Authors:  M A Monnickendam; S Darougar; J D Treharne; A M Tilbury
Journal:  Br J Ophthalmol       Date:  1980-04       Impact factor: 4.638

View more
  17 in total

1.  Chlamydia trachomatis pneumonia induces in vivo production of interleukin-1 and -6.

Authors:  D M Magee; J G Smith; C A Bleicker; C J Carter; L F Bonewald; J Schachter; D M Williams
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

2.  Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis.

Authors:  S J Rasmussen; L Eckmann; A J Quayle; L Shen; Y X Zhang; D J Anderson; J Fierer; R S Stephens; M F Kagnoff
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

3.  Chlamydia trachomatis-induced production of interleukin-1 by human monocytes.

Authors:  C D Rothermel; J Schachter; P Lavrich; E C Lipsitz; T Francus
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

4.  The microbial epidemiology of trachoma.

Authors:  J D Treharne
Journal:  Int Ophthalmol       Date:  1988       Impact factor: 2.031

5.  Cytotoxic-T-lymphocyte-mediated cytolysis of L cells persistently infected with Chlamydia spp.

Authors:  S J Rasmussen; P Timms; P R Beatty; R S Stephens
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

6.  Chlamydial genital infection in prostitutes in Iran.

Authors:  S Darougar; B Aramesh; J A Gibson; J D Treharne; B R Jones
Journal:  Br J Vener Dis       Date:  1983-02

7.  Ocular and dermal delayed hypersensitivity reactions in guinea-pigs following infection with guinea-pig inclusion conjunctivitis agent (Chlamydia psittaci).

Authors:  M A Monnickendam; S Darougar; A M Tilbury
Journal:  Clin Exp Immunol       Date:  1981-04       Impact factor: 4.330

8.  Responses to tuberculin in the guinea-pig eye as a model of cell mediated immune responses in the external eye.

Authors:  R S Dwyer; S Darougar; M A Monnickendam
Journal:  Br J Ophthalmol       Date:  1987-04       Impact factor: 4.638

9.  Chlamydial pelvic infection in cats: a model for the study of human pelvic inflammatory disease.

Authors:  J L Kane; R M Woodland; M G Elder; S Darougar
Journal:  Genitourin Med       Date:  1985-10

10.  Protein antigens of Chlamydia psittaci present in infected cells but not detected in the infectious elementary body.

Authors:  D D Rockey; J L Rosquist
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.